/GEHC
GE HealthCare Technologies Inc.
GEHC • NASDAQGEHC • NASDAQ • Healthcare
$70.33-3.19%-2.32
$70.33-3.19%(-2.32)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
73Low Risk
Momentum
24Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
40.0%▼1.7pp
Revenue after COGS
Operating
13.4%▲0.0pp
After operating expenses
Net
10.1%▼0.0pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
18.0
Price vs earnings
EV/EBITDA
11.3
Enterprise value
FCF Yield
4.0%
Cash generation
Earnings Yield
5.6%
Inverse of P/E
Capital Efficiency
12
GoAI Quality ScoreFair
ROEReturn on Equity
20.1%Strong
ROAReturn on Assets
5.6%Strong
ROICReturn on Invested Capital
8.8%Fair
Financial Health
Current RatioAdequate
1.18
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
1.45x
Debt repayment capacity (<3x)
Income QualityFair
0.92
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $20.63B | $19.67B | $19.55B | $18.34B | $17.59B |
| Gross Profit | $8.25B | $8.21B | $7.92B | $7.18B | $7.17B |
| Gross Margin | 40.0% | 41.7% | 40.5% | 39.1% | 40.8% |
| Operating Income | $2.76B | $2.63B | $2.44B | $2.52B | $2.79B |
| Net Income | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B |
| Net Margin | 10.1% | 10.1% | 8.0% | 10.4% | 12.8% |
| EPS | $4.56 | $4.37 | $3.04 | $4.22 | $4.90 |
Average Price Target
$91.70▲ 30.4% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for GE HealthCare Technologies Inc., the average price target is $91.70, with a high forecast of $105.00 and a low forecast of $77.00. The average price target represents a 30.4% increase from the current price of $70.33.
Highest
$105.00
Average
$91.70
Lowest
$77.00
Rating Distribution
Strong Buy
0
0%
Buy
11
65%
Hold
5
29%
Sell
1
6%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Citigroup● Maintain
Neutral
2026-03-11BTIG● Maintain
Buy
2026-02-09Barclays● Maintain
Equal Weight
2026-02-06Wells Fargo● Maintain
Overweight
2026-02-05Morgan Stanley● Maintain
Equal Weight
2026-02-05Evercore ISI Group● Maintain
Outperform
2026-02-05Stifel● Maintain
Buy
2026-02-05BTIG● Maintain
Buy
2026-02-04Piper Sandler● Maintain
Overweight
2026-01-30UBS▼ Downgrade
Neutral→Sell
2026-01-15Earnings History & Surprises
BEAT RATE
92%
Last 12 quarters
AVG SURPRISE
+7.4%
EPS vs Estimate
BEATS / MISSES
11/1
Last 12 quarters
LATEST EPS
$1.44
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+2.9%
$1.44 vs $1.40
Q4 '25
+1.9%
$1.07 vs $1.05
Q3 '25
+15.5%
$1.06 vs $0.92
Q2 '25
+10.5%
$1.01 vs $0.91
Q1 '25
+15.1%
$1.45 vs $1.26
Q4 '24
+8.6%
$1.14 vs $1.05
Q3 '24
+2.0%
$1.00 vs $0.98
Q2 '24
-1.1%
$0.90 vs $0.91
Q1 '24
+10.3%
$1.18 vs $1.07
Q4 '23
+10.0%
$0.99 vs $0.90
Q3 '23
+5.7%
$0.92 vs $0.87
Q2 '23
+7.6%
$0.85 vs $0.79
No investor questions available.
Latest News
No news available